Trial intelligence / Profile preview

Intrathecal Morphine and Bupivacaine for Post-Hepatectomy Analgesia

NCT05208801Completed

Sponsor
Yonsei University
Start
Nov 2018
Primary completion
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by Yonsei University. Primary endpoint: Time to first rescue analgesic at 72 hours. Started Nov 2018; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05208801.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05208801.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call